Skip to menu Skip to content Skip to footer

2025

Journal Article

The complexities of elexacaftor/tezacaftor/ivacaftor therapeutic drug monitoring in a person with cystic fibrosis and <i>Mycobacterium abscessus</i> pulmonary disease

Mou, Claire Y, Henderson, Daniel J, Matson, Angela G, Herd, Karen M, Reid, David W, Riddles, Timothy, Johnson, Ellie, McWhinney, Brett, Swenson, Rebecca, Burke, Andrew and Evans, Ieuan E S (2025). The complexities of elexacaftor/tezacaftor/ivacaftor therapeutic drug monitoring in a person with cystic fibrosis and Mycobacterium abscessus pulmonary disease. European Clinical Respiratory Journal, 12 (1) 2458341, 2458341. doi: 10.1080/20018525.2025.2458341

The complexities of elexacaftor/tezacaftor/ivacaftor therapeutic drug monitoring in a person with cystic fibrosis and <i>Mycobacterium abscessus</i> pulmonary disease

2025

Journal Article

Evaluating the feasibility, sensitivity, and specificity of next-generation molecular methods for pleural infection diagnosis

Bell, Peter T., Baird, Timothy, Goddard, John, Olagoke, Olusola S., Burke, Andrew, Subedi, Shradha, Davey, Tiana R., Anderson, James, Sarovich, Derek S. and Price, Erin P. (2025). Evaluating the feasibility, sensitivity, and specificity of next-generation molecular methods for pleural infection diagnosis. Microbiology Spectrum, 13 (2). doi: 10.1128/spectrum.01960-24

Evaluating the feasibility, sensitivity, and specificity of next-generation molecular methods for pleural infection diagnosis

2024

Conference Publication

Rifabutin induces Elexacaftor metabolism in Mycobacterium abscessus-related pulmonary disease: A case study

Mattison, Graeme, Keating, Rebecca, McWhinney, Brett, Connors, Shannon, Swenson, Rebecca, Evans, Ieuan, Burke, Andrew and Burr, Lucy (2024). Rifabutin induces Elexacaftor metabolism in Mycobacterium abscessus-related pulmonary disease: A case study. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD Australia, 2–4 August 2024. Richmond, VIC Australia: John Wiley & Sons.

Rifabutin induces Elexacaftor metabolism in Mycobacterium abscessus-related pulmonary disease: A case study

2024

Journal Article

New oxazolidinones for tuberculosis: are novel treatments on the horizon?

Chen, Ricky Hao, Burke, Andrew, Cho, Jin-Gun, Alffenaar, Jan-Willem and Davies Forsman, Lina (2024). New oxazolidinones for tuberculosis: are novel treatments on the horizon?. Pharmaceutics, 16 (6) 818. doi: 10.3390/pharmaceutics16060818

New oxazolidinones for tuberculosis: are novel treatments on the horizon?

2024

Journal Article

OPTIMA: an open-label, non-comparative pilot trial of inhaled molgramostim in pulmonary nontuberculous mycobacterial infection

Thomson, Rachel M., Loebinger, Michael R., Burke, Andrew J., Morgan, Lucy C., Waterer, Grant W. and Ganslandt, Cecilia (2024). OPTIMA: an open-label, non-comparative pilot trial of inhaled molgramostim in pulmonary nontuberculous mycobacterial infection. Annals of the American Thoracic Society, 21 (4), 568-576. doi: 10.1513/annalsats.202306-532oc

OPTIMA: an open-label, non-comparative pilot trial of inhaled molgramostim in pulmonary nontuberculous mycobacterial infection

2024

Journal Article

Prevalence, risk factors, clinical features, and outcome of Influenza-Associated Pulmonary Aspergillosis (IAPA) in critically ill patients: a systematic review and meta-analysis

Lu, Lawrence Y., Lee, Hui Min, Burke, Andrew, Li Bassi, Gianluigi, Torres, Antoni, Fraser, John F. and Fanning, Jonathon P. (2024). Prevalence, risk factors, clinical features, and outcome of Influenza-Associated Pulmonary Aspergillosis (IAPA) in critically ill patients: a systematic review and meta-analysis. CHEST, 165 (3), 540-558. doi: 10.1016/j.chest.2023.09.019

Prevalence, risk factors, clinical features, and outcome of Influenza-Associated Pulmonary Aspergillosis (IAPA) in critically ill patients: a systematic review and meta-analysis

2024

Journal Article

A case of severe Mycobacterium thermoresistibile pneumonia

Subramaniam, Selvaraj, Kanhere, Mrudula, Shephard, Lisa, Burke, Andrew, Saxon, Sarah and Geake, James (2024). A case of severe Mycobacterium thermoresistibile pneumonia. Respirology Case Reports, 12 (3) e01308, 1-6. doi: 10.1002/rcr2.1308

A case of severe Mycobacterium thermoresistibile pneumonia

2023

Journal Article

Medications and monitoring in treatment of nontuberculous mycobacteria lung disease

Sawka, Alice and Burke, Andrew (2023). Medications and monitoring in treatment of nontuberculous mycobacteria lung disease. Clinics in Chest Medicine, 44 (4), 815-828. doi: 10.1016/j.ccm.2023.06.012

Medications and monitoring in treatment of nontuberculous mycobacteria lung disease

2023

Journal Article

A randomized trial of Nafamostat for Covid-19

Morpeth, Susan C., Venkatesh, Balasubramanian, Totterdell, James A., McPhee, Grace M., Mahar, Robert K., Jones, Mark, Bandara, Methma, Barina, Lauren A., Basnet, Bhupendra K., Bowen, Asha C., Burke, Andrew J., Cochrane, Belinda, Denholm, Justin T., Dhungana, Ashesh, Dore, Gregory J., Dotel, Ravindra, Duffy, Eamon, Dummer, Jack, Foo, Hong, Gilbey, Timothy L., Hammond, Naomi E., Hudson, Bernard J., Jha, Vivekanand, Jevaji, Purnima R., John, Oommen, Joshi, Rajesh, Kang, Gagandeep, Kaur, Baldeep, Kim, Seungtaek ... Tong, Steven Y.C. (2023). A randomized trial of Nafamostat for Covid-19. NEJM Evidence, 2 (11). doi: 10.1056/evidoa2300132

A randomized trial of Nafamostat for Covid-19

2023

Journal Article

In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolates

Burke, Andrew, Carter, Robyn, Tolson, Carla, Congdon, Jacob, Duplancic, Christine, Bursle, Evan, Bell, Scott C., Roberts, Jason A. and Thomson, Rachel (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolates. International Journal of Antimicrobial Agents, 62 (4) 106938, 1-6. doi: 10.1016/j.ijantimicag.2023.106938

In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolates

2023

Journal Article

Pre-XDR congenital tuberculosis in an extremely premature baby

Boast, Alison, How, Jeu Ann, Lau, Charis, Sett, Arun, Gilby, Damian, Burke, Andrew, McWhinney, Brett, Wright, Connor, Tramontana, Adrian, Globan, Maria, Denholm, Justin, Graham, Stephen M and Osowicki, Joshua (2023). Pre-XDR congenital tuberculosis in an extremely premature baby. Clinical Infectious Diseases, 78 (1), 149-153. doi: 10.1093/cid/ciad540

Pre-XDR congenital tuberculosis in an extremely premature baby

2023

Journal Article

A mariner's tale: invasive endotracheal Mycobacterium marinum infection

Bell, Peter T., Anderson, James, Coulter, Christopher, Dettrick, Andrew J., Burke, Andrew and Baird, Timothy (2023). A mariner's tale: invasive endotracheal Mycobacterium marinum infection. Respirology Case Reports, 11 (10) e01211, e01211. doi: 10.1002/rcr2.1211

A mariner's tale: invasive endotracheal Mycobacterium marinum infection

2023

Journal Article

Mycoplasma hominis and Ureaplasma urealyticum infections in the immediate post-lung transplant period: A case series and literature review

Divithotewala, Chandima, Sweeney, Emma L., Burke, Andrew, Graves, Bianca, Stewart, Adam, Whiley, David, Heney, Claire, Hopkins, Peter M. and Chambers, Daniel C. (2023). Mycoplasma hominis and Ureaplasma urealyticum infections in the immediate post-lung transplant period: A case series and literature review. Transplant Infectious Disease, 25 (3) e14058, 1-7. doi: 10.1111/tid.14058

Mycoplasma hominis and Ureaplasma urealyticum infections in the immediate post-lung transplant period: A case series and literature review

2023

Journal Article

Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators

Burke, Andrew, Thomson, Rachel M., Wainwright, Claire E. and Bell, Scott C. (2023). Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators. Seminars in Respiratory and Critical Care Medicine, 44 (02), 287-296. doi: 10.1055/s-0042-1759883

Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators

2022

Journal Article

Anticoagulation strategies in non–critically ill patients with Covid-19

McQuilten, Zoe K., Venkatesh, Balasubramanian, Jha, Vivekanand, Roberts, Jason, Morpeth, Susan C., Totterdell, James A., McPhee, Grace M., Abraham, John, Bam, Niraj, Bandara, Methma, Bangi, Ashpak K., Barina, Lauren A., Basnet, Bhupendra K., Bhally, Hasan, Bhusal, Khema R., Bogati, Umesh, Bowen, Asha C., Burke, Andrew J., Christopher, Devasahayam J., Chunilal, Sanjeev D., Cochrane, Belinda, Curnow, Jennifer L., Das, Santa Kumar, Dhungana, Ashesh, Di Tanna, Gian Luca, Dotel, Ravindra, DSouza, Hyjel, Dummer, Jack, Dutta, Sourabh ... Tong, Steven Y.C. (2022). Anticoagulation strategies in non–critically ill patients with Covid-19. NEJM Evidence, 2 (2). doi: 10.1056/evidoa2200293

Anticoagulation strategies in non–critically ill patients with Covid-19

2022

Journal Article

Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion

Fitzgerald, Deirdre B., Sidhu, Calvin, Budgeon, Charley, Tan, Ai Ling, Read, Catherine A., Kwan, Benjamin C. H., Smith, Nicola Ann, Fysh, Edward T., Muruganandan, Sanjeevan, Saghaie, Tajalli, Shrestha, Ranjan, Badiei, Arash, Nguyen, Phan, Burke, Andrew, Goddard, John, Windsor, Morgan, McDonald, Julie, Wright, Gavin, Czarnecka, Kasia, Sivakumar, Parthipan, Yasufuku, Kazuhiro, Feller-Kopman, David J., Maskell, Nick A., Murray, Kevin and Lee, Y. C. Gary (2022). Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion. Trials, 23 (1) 530, 1-9. doi: 10.1186/s13063-022-06405-7

Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion

2022

Conference Publication

Anticoagulation and antiplatelet strategies in non-critically ill patients with Covid-19

McQuilten, Zoe, Venkatesh, Balasubramanian, Jha, Vivekanand, Roberts, Jason, Morpeth, Susan, Totterdell, James, McPhee, Grace, Abraham, John, Bam, Niraj, Bandara, Methma, Bangi, Ashpak, Barina, Lauren, Basnet, Bhupendra, Bhally, Hasan, Bhusal, Khemr, Bogati, Umesh, Bowen, Asha, Burke, Andrew, Christopher, Devasahayam, Chunilal, Sanjeev, Cochrane, Belinda, Curnow, Jennifer, Reddy, Varaprasad Babu Dara, Das, Santa, Dhungana, Ashesh, Di Tanna, Gian Luca, Dotel, Ravindra, DSouza, Hyjel, Dummer, Jack ... Tong, Steven Y. C. (2022). Anticoagulation and antiplatelet strategies in non-critically ill patients with Covid-19. 64th Annual Meeting and Exposition of the American Society of Hematology (ASH), New Orleans, LA United States, 10-13 December 2022. Amsterdam, Netherlands: Elsevier. doi: 10.1182/blood-2022-168448

Anticoagulation and antiplatelet strategies in non-critically ill patients with Covid-19

2022

Journal Article

The IRIS paradox: Imaging findings in a case of PJP-IRIS

Reddy, Taryn, Bajwa, Ramey and Burke, Andrew (2022). The IRIS paradox: Imaging findings in a case of PJP-IRIS. Respirology Case Reports, 10 (9) e01014. doi: 10.1002/rcr2.1014

The IRIS paradox: Imaging findings in a case of PJP-IRIS

2022

Journal Article

Screening for obstructive sleep apnoea in patients with serious mental illness

Zhang, Lai-Ying, Anderson, James, Higgins, Niall, Robinson, Jan, Francey, Sonia, Burke, Andrew, Robinson, Gail, Curtin, Deanne and Tay, George (2022). Screening for obstructive sleep apnoea in patients with serious mental illness. Australasian Psychiatry, 30 (5), 615-618. doi: 10.1177/10398562221108632

Screening for obstructive sleep apnoea in patients with serious mental illness

2022

Journal Article

Evidence of safety for pretomanid and male reproductive health

Burke, A., Alffenaar, J. and Denholm, J. (2022). Evidence of safety for pretomanid and male reproductive health. The International Journal of Tuberculosis and Lung Disease, 26 (6), 473-474. doi: 10.5588/ijtld.22.0092

Evidence of safety for pretomanid and male reproductive health